Exact Sciences Corporation
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated wit…
Medical - Diagnostics & Research
US, Madison [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Exact Sciences Corporation's gradings, price targets and earnings estimates. None
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | -0.6900 | -1.040 | 4 | 1 | -46 | -89 | -46 | -86 | -46 | -90 | 23 | 1 |
| 2015 | -1.2500 | -1.770 | 1 | 39 | -100 | -162 | -100 | -154 | -100 | -164 | 69 | 31 |
| 2016 | -1.7100 | -1.691 | 39 | 97 | -157 | -187 | -159 | -174 | -159 | -189 | 140 | 76 |
| 2017 | -1.6300 | -1.046 | 99 | 265 | -167 | -140 | -169 | -121 | -169 | -145 | 189 | 207 |
| 2018 | -0.9900 | -1.483 | 265 | 446 | -114 | -192 | -118 | -126 | -118 | -175 | 262 | 349 |
| 2019 | -1.4300 | -1.622 | 454 | 878 | -175 | 65 | -159 | -312 | -159 | -462 | 427 | 686 |
| 2020 | -0.6400 | -2.977 | 876 | 1,468 | -83 | -4,554 | -217 | -3,802 | -233 | -4,294 | 737 | 1,147 |
| 2021 | -5.6100 | -3.110 | 1,491 | 1,743 | -848 | -483 | -464 | -694 | -558 | -919 | 1,071 | 1,677 |
| 2022 | -3.4800 | -3.633 | 1,767 | 2,053 | -595 | -726 | -740 | -533 | -835 | -710 | 1,663 | 1,635 |
| 2023 | -3.5400 | -1.283 | 2,084 | 2,490 | -623 | -175 | -480 | -586 | -577 | -781 | 1,583 | 1,798 |
| 2024 | -1.1300 | -0.931 | 2,499 | 2,831 | -204 | -167 | -13 | -688 | -214 | -972 | 1,620 | 2,214 |
| 2025 | - | 0.138 | - | 3,217 | - | -12 | - | -781 | - | -1,105 | - | 2,515 |
| 2026 | - | 1.023 | - | 3,612 | - | 136 | - | -877 | - | -1,241 | - | 2,824 |
| 2027 | - | 1.322 | - | 3,929 | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
| 2028 | - | 1.703 | - | 4,160 | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |